1-(2,3-difluorobenzyl)-1H-indazol-5-amine → (1-(2,3-Difluorobenzyl)-1H-indazol-5-yl)-(6-(5-methyl-1,3,4-oxadiazol-2-yl)quinazolin-4-yl)-amine hydrochloride
Reaction equation
[F:1][C:2]1[C:18]([F:19])=[CH:17][CH:16]=[CH:15][C:3]=1[CH2:4][N:5]1[C:13]2[C:8](=[CH:9][C:10]([NH2:14])=[CH:11][CH:12]=2)[CH:7]=[N:6]1.[Cl:20][C:21]1[C:30]2[C:25](=[CH:26][CH:27]=[C:28]([C:31]3[O:32][C:33]([CH3:36])=[N:34][N:35]=3)[CH:29]=2)[N:24]=[CH:23][N:22]=1>>[ClH:20].[F:1][C:2]1[C:18]([F:19])=[CH:17][CH:16]=[CH:15][C:3]=1[CH2:4][N:5]1[C:13]2[C:8](=[CH:9][C:10]([NH:14][C:21]3[C:30]4[C:25](=[CH:26][CH:27]=[C:28]([C:31]5[O:32][C:33]([CH3:36])=[N:34][N:35]=5)[CH:29]=4)[N:24]=[CH:23][N:22]=3)=[CH:11][CH:12]=2)[CH:7]=[N:6]1Participants
3
Procedure
The title compound was prepared according to Procedure A from 1-(2,3-difluorobenzyl)-1H-indazol-5-ylamine and 4-chloro-6-(5-methyl-1,3,4-oxadiazol-2-yl)-quinazoline; δH [2H6]DMSO 11.90(1H, s), 9.47(1H, s), 8.91(1H, s), 8.60(1H, d), 8.25(1H, s), 8.15(2H, m), 7.89(1H, d), 7.72(1H, dd), 7.40(1H, m), 7.18(1H, m), 6.98(1H, m), 5.83(2H, s), 2.67(3H, s); m/z (M+1+) 470.
Sources & evidence
- ORD record
- ord-f7b457b46e2843e182311a35d2697e92
- Source dataset
- uspto-grants-2004_12
- Patent number
- US06828320B2
Reaction notes
Loading…